Approval · Notice of Compliance 5405 · 2004
VIRACEPT: Notice of Compliance 5405
Issued September 21, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5405
- Date
- September 21, 2004
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New information for use in children and neonates, change in dosing recommendations for children 2 to 13 years of age
- Therapeutic class
- Hiv protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIRACEPT | Not yet assigned | — |
Medicinal ingredients
- NELFINAVIR MESYLATE 250 MG per TAB
- NELFINAVIR MESYLATE 50 MG per G